undefined
EUTM file information

018875811

ABRYSVO


May 15, 2023

Trademark Summary

The trademark ABRYSVO was filed by PFIZER INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 13, 2023, and received one opposition filed on August 28, 2023 by Merck KGaA on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 28, 2023

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

The Opposition with reference B 003202071 was rejected according to Article 10(2) EUTMDR with decision issued on October 15, 2024 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations, namely, vaccines for the prevention of Respiratory Syncytial Virus Infection, none of the aforesaid for animals or for veterinary use.